Price (delayed)
$37.795
Market cap
$1.97B
P/E Ratio
48.46
Dividend/share
N/A
EPS
$0.78
Enterprise value
$2.73B
NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes.
There are no recent dividends present for NUVA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.